Investor

Guidant

Last cheque observed Jul 2004. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietCorporate VC

Series CSeries BSeries EBiotechnologyHealth CareManufacturing

Cheques on record
0%of best year0cheques in 12 months, 6 on record
Since the last cheque8139days00hrs00min00sec
Median round$15MRounds led0 of 6Sole investor1 roundsExits2 from the portfolioMostly inUnited States, 100%
Pitch Guidant

Guidant highlights

  1. 01

    6 rounds on record

  2. 02

    Mostly Series C and Series B: 67% of its rounds

  3. 03

    Sole investor in 1 rounds, median undisclosed

  4. 04

    2 exits from the portfolio

What they do

Type
Corporate VC (from a list, unverified)
Cheque size
Not stated
Sectors
BiotechnologyHealth CareManufacturing
Cold pitches
Not stated

The record

Every round we can evidence, newest first6 appearances

  1. 2004

    3 rounds

  2. Jul
    IntrapaceSeries C · US$15MWith 6 others
  3. May
    EvalveSeries C · US$35MWith 6 others
  4. Jan
    SpirationSeries E · US$27MWith 6 others
  5. 2003

    2 rounds

  6. Nov
    CardioMEMSSeries B · US$14MWith 4 others
  7. Jan
    CardioNetSeries C · US$13MWith 3 others
  8. 2001

    1 round

  9. Jun
    BioheartVenture · USUndisclosedSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

EvalveBought by Abbott Labs$410MSept 2009
CardioMEMSBought by St. Jude MedicalUndisclosedNov 2003

An exit counts when it came after the firm's first round in the company. From historical deal records.

Companies it bought

Acquisitions by the firm itself

AFxUndisclosedFeb 2004
SynecorUndisclosedApr 2003

Who they invest alongside

The investors most often in the same rounds as Guidant. A count of rooms they were both in, not a relationship either has claimed.

Johnson & Johnson Development Corporation (JJDC)VC firm2rounds togetherNew Enterprise AssociatesVC firm2rounds togetherThree Arch PartnersGrowth equity2rounds together

Quick answers about Guidant

What does Guidant invest in?

Guidant invests most often at Series C and Series B (67% of the rounds on record), in sectors such as Biotechnology, Health Care and Manufacturing.

How active is Guidant?

6 investments on record, 0 of them in the last 12 months. The most recent was in Jul 2004.

How big are Guidant's cheques?

The median round it joins is $15M.

Does Guidant lead rounds?

Rarely, if at all: none of its 6 investments on record names it as the lead.

Where does Guidant invest?

Most of the companies it backs are in the United States (100%).

Is Guidant investing now?

No investments in the last 12 months; the latest was in Jul 2004.

Who does Guidant invest alongside?

Most often Johnson & Johnson Development Corporation (JJDC) (2 rounds together), New Enterprise Associates (2 rounds together) and Three Arch Partners (2 rounds together).

What kind of investor is Guidant?

Guidant is a corporate VC.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it